BE550159A - - Google Patents

Info

Publication number
BE550159A
BE550159A BE550159DA BE550159A BE 550159 A BE550159 A BE 550159A BE 550159D A BE550159D A BE 550159DA BE 550159 A BE550159 A BE 550159A
Authority
BE
Belgium
Prior art keywords
sep
ferrous
iron
complex
compounds
Prior art date
Application number
Other languages
English (en)
French (fr)
Publication of BE550159A publication Critical patent/BE550159A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE550159D BE550159A (enExample)

Publications (1)

Publication Number Publication Date
BE550159A true BE550159A (enExample)

Family

ID=176147

Family Applications (1)

Application Number Title Priority Date Filing Date
BE550159D BE550159A (enExample)

Country Status (1)

Country Link
BE (1) BE550159A (enExample)

Similar Documents

Publication Publication Date Title
EP2744487B1 (en) No- and h2s- releasing compounds
CN104673865B (zh) 具有降尿酸作用的秋刀鱼美拉德肽及其制备方法和用途
Zingales et al. Role of quercetin on sterigmatocystin-induced oxidative stress-mediated toxicity
BE550159A (enExample)
GB2094142A (en) Injectable solution containing theophylline and a basic amino acid
CN117466286A (zh) 一种基于大黄酸的红色荧光碳量子点及其制备方法
PT2323625T (pt) Nova composição para o tratamento de pigmentações equimóticas
CN117384374A (zh) FTEP-TBFc化合物的制备方法和在抗肿瘤中的应用
CN106999455A (zh) 改性牛磺酸以及含有改性牛磺酸的用于预防或治疗代谢疾病的药物组合物
CN106478946B (zh) 一种可降解的聚苯胺/多孔硅纳米复合材料及其制备方法和应用
US2245610A (en) Medicinal composition
JPS6355489B2 (enExample)
CN101400262A (zh) 新植酸柠檬酸化合物及其制备方法
US252203A (en) Otto fischer
CN110151781A (zh) 一种治疗痔疮的药液及其制备方法
US736529A (en) Formaldehyde compound.
WO2007109845A1 (en) Prophylaxis or treatment of diabetes
US10413570B2 (en) Method of manufacturing a zinc compound lozenge
JP4678661B2 (ja) 新規なテトラキスアミノフェニル（ジ）フェニレンジアミン骨格を有する化合物
JP2024025110A (ja) 光線力学的療法のための光感受性物質
AT77319B (de) Verfahren zur Darstellung von wasserlöslichen Verbindungen des Cystins und dessen Derivaten mit Desinfizientien zur Bekämpfung von Typhus und anderen Infektionskrankheiten, die in der Leber ihrer Ursprung haben.
JPS58148850A (ja) プロピオニルグリシン誘導体、その製造方法及びそれを活性成分として含む治療用組成物
BE440267A (enExample)
Kirpatovsky et al. Comparative analysis of secretory and reabsorbing activity of ileal and sigmoid mucosa, employed for urinary bladder intestinoplasty
RU2163816C1 (ru) Способ получения средства для лечения неонкологических патологий организма